Sickle Cell Disease

← Back to Class List

PDL Status Values

Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the Non-Preferred Drugs in Select PDL Classes prior authorization criteria. New drugs will be listed as N until reviewed by the P&T Committee and are subject to the New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.

To request a Prior Authorization, please use this form.

< Return to summary view

NDC Brand Name Generic Name Form Strength PDL
Status
Rebate Current Drug Use Criteria
00078088361 ADAKVEO crizanlizumab-tmca VIAL 100 mg/10 mL (10 mg/mL) N Y PA Document
42457042001 ENDARI glutamine POWD PACK 5 gram N Y PA Document
42457042060 ENDARI glutamine POWD PACK 5 gram N Y PA Document
70954041710 L-GLUTAMINE glutamine POWD PACK 5 gram N Y PA Document
70954041720 L-GLUTAMINE glutamine POWD PACK 5 gram N Y PA Document
61269040260 DROXIA hydroxyurea CAPSULE 200 mg N Y  
61269040360 DROXIA hydroxyurea CAPSULE 300 mg N Y  
61269040460 DROXIA hydroxyurea CAPSULE 400 mg N Y  
61269083510 HYDREA hydroxyurea CAPSULE 500 mg Y Y  
00555088202 HYDROXYUREA hydroxyurea CAPSULE 500 mg Y Y  
00904693961 HYDROXYUREA hydroxyurea CAPSULE 500 mg Y Y  
49884072401 HYDROXYUREA hydroxyurea CAPSULE 500 mg Y Y  
51285054802 HYDROXYUREA hydroxyurea CAPSULE 500 mg Y Y  
68084028401 HYDROXYUREA hydroxyurea CAPSULE 500 mg Y Y  
68084028411 HYDROXYUREA hydroxyurea CAPSULE 500 mg Y Y  
69315016401 HYDROXYUREA hydroxyurea CAPSULE 500 mg Y Y  
70069082001 HYDROXYUREA hydroxyurea CAPSULE 500 mg Y Y  
62484001504 XROMI hydroxyurea SOLUTION 100 mg/mL N Y  
62484001505 XROMI hydroxyurea SOLUTION 100 mg/mL N Y  
71770012030 SIKLOS hydroxyurea TABLET 1,000 mg N Y  
71770010560 SIKLOS hydroxyurea TABLET 100 mg N Y